Lazurite

Executive Summary

Lazurite is a US-based medical device company that has developed the ArthroFree system, the first FDA-cleared wireless camera platform for arthroscopic and endoscopic surgery. Founded in 2016 and headquartered in Cleveland, Ohio, the company aims to transform surgical workflows by eliminating the need for wired cameras, thereby improving surgeon maneuverability, reducing procedural setup time, and lowering costs per procedure. The ArthroFree system addresses a significant pain point in minimally invasive surgery, where tangled cables and restricted movement can hinder efficiency and increase turnover times. By offering a fully wireless solution, Lazurite enables greater freedom of movement for surgeons and reduces the risk of intraoperative disruptions, potentially leading to better patient outcomes and operating room utilization. The company's initial focus on arthroscopic and endoscopic procedures positions it in a large and growing market, with opportunities for expansion into other surgical specialties. While still early in commercialization, Lazurite's innovative technology and first-mover advantage in wireless surgical cameras give it a competitive edge in the medical device landscape. The company's ability to scale manufacturing, secure reimbursement, and build clinical evidence will be critical to its success.

Upcoming Catalysts (preview)

• Q2 2027Expansion of FDA clearance to additional surgical indications (e.g., laparoscopy)60% success
• Q4 2026Strategic partnership or distribution agreement with a major surgical device company70% success
• Q3 2026Publication of pivotal clinical data demonstrating improved surgical outcomes and cost savings75% success